Tilmicosin formulation
US5574020A · kind A · utility
15Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 1995 |
| Grant date | Nov 12, 1996 |
| Priority date | — |
| Expiry date | Jan 13, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/706
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An aqueous, injectable, sustained release tilmicosin formulation comprises 250-350 mg/ml of tilmicosin and 250 mg/ml of propylene glycol, and has a pH adjusted to 6.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.